Momentis Surgical

Company Overview

Snapshot

Founded in August 2012 by Nir Shvalb, Momentis Surgical operates with 51–200 employees. The company has raised $128.45 million across 8 funding rounds from 7 investors. In October 2024, Momentis Surgical received FDA 510(k) clearance for its Anovo robotic system, expanding into the general surgery market.

Business overview

Momentis Surgical is a Health Tech & Life Sciences company focused on transforming robotic-assisted surgery. The company develops the Anovo Surgical System, which features humanoid-shaped miniature robotic arms designed with human dexterity, superhuman flexibility, and 360-degree articulation. This technology provides exceptional access and maneuverability for single-site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures. The Anovo system aims to make robotic surgery more accessible and cost-effective for hospitals and ambulatory surgery centers, operating within the medical devices, medical treatment, and therapeutics sectors.

Strategic signal

Momentis Surgical received FDA 510(k) clearance for its Anovo robotic system in October 2024, enabling its expansion into the general surgery market. This regulatory approval is a significant validation of the company's technology and signals a substantial growth opportunity, allowing Momentis Surgical to address a broader range of surgical procedures and increase its market penetration beyond its initial focus on gynecological surgeries.

Company Intelligence Q&A

What is the primary product offered by Momentis Surgical?

Momentis Surgical offers the Anovo Surgical System, a robot-assisted platform featuring miniature robotic arms designed for high dexterity and flexibility in surgical procedures.

When did Momentis Surgical receive FDA clearance for its Anovo robotic system for general surgery?

In October 2024, Momentis Surgical received FDA 510(k) clearance for its Anovo robotic system, allowing its expansion into the general surgery market.

Which hospital adopted the Anovo Surgical System in September 2022?

In September 2022, Lee Health adopted Momentis Surgical's Anovo Surgical System for robotic-assisted benign gynecological surgeries.

What was a significant operational change for Momentis Surgical in May 2023?

In May 2023, Momentis Surgical underwent a significant operational change, cutting 60% of its team.

When did Momentis Surgical receive FDA De Novo marketing authorization for its first surgical robotic system?

In March 2021, Momentis Surgical received FDA De Novo marketing authorization for its first surgical robotic system with humanoid-shaped robotic arms.